| Proportion receiving test |  | |
---|---|---|---|
Test | Baseline | Endline | p value |
Tests before 16 weeks | |||
Hb | 0/707 (0% [95% CI 0–1]) | 70/894 (8% [95% CI 6–10]) | < 0.001 |
HIV | 42/647 (6% [95% CI 5–9]) | 78/836 (9% [95% CI 7–12]) | 0.069 |
Malaria | 0/707 (0% [95% CI 0–1]) | 38/894 (4% [95% CI 3–6]) | < 0.001 |
RPR | 39/707 (6% [95% CI 4–7]) | 73/894 (8% [95% CI 6–10]) | 0.061 |
All four tests | 0/707 (0% [95% CI 0–1]) | 29/894 (3% [95% CI 2–5]) | < 0.001 |
Tests at any time | |||
Hb | 0/707 (0% [95% CI 0–1]) | 546/894 (61% [95% CI 58–64]) | < 0.001 |
HIV | 336/647 (52% [95% CI 48–56]) | 489/836 (58% [95% CI 55–62]) | 0.188 |
Malaria | 0/707 (0% [95% CI 0–1]) | 189/894 (21% [95% CI 19–24]) | < 0.001 |
RPR | 312/707 (44% [95% CI 40–48]) | 478/894 (53% [95% CI 50–57]) | 0.031 |
All four tests | 0/707 (0% [95% CI 0–1]) | 148/894 (17% [95% CI 14–19]) | < 0.001 |